MOLM-13

Acute Monocytic leukemia cell line established from peripheral blood of an AML patient

Cell Type:
Monocyte
Tissue Origin:
blood
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
SF EH-100 CRISPR/Cas 100 µl 4D X-Unit
SF CA-137 2e6 siRNA 2 µM 100 µl 4D X-Unit

Citations

Categories:
Transfection, Cell Lines and Primary Cancer Cells 
Authors:
Dykstra KM, Fay HRS, Massey AC, Yang N, Johnson M, Portwood S, Guzman ML, Wang ES.  
In:
Blood (2021) 5(8): 2087-2100 
Categories:
Transfection 
Authors:
Brinton LT, Sher S, Williams K, Canfield D, Orwick S, Wasmuth R, Cempre C, Skinner J, Lehman A, Blachly JS, Byrd JC, Lapalombella R. 
In:
Cancers (2020) 12(6): 1574 
Categories:
Transfection 
Authors:
Caligiuri MA, Briesewitz R, Yu J, Wang L, Wei M, Arnoczky KJ, Marburger TB, Wen J, Perrotti D, Bloomfield CD, Whitman SP 
In:
Blood (2007) 110(3): 1022-4